Clinical Trial Update: Multicenter Hologic Tomosynthesis Study [NA]

View source ↗

Summary

A multicenter tomosynthesis study sponsored by Hologic for breast cancer imaging has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hologic, Inc. | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2025-02-26